Abstract
G protein-coupled receptors have been proposed to exist in signalosomes subject to agonist-driven shifts in the assembly disassembly equilibrium, affected by stabilizing membrane lipids and/or cortical actin restricting mobility. We investigated the highly homologous corticotropin-releasing factor receptors (CRFRs), CRFR1 and -2, which are different within their hydrophobic core. Agonist stimulation of CRFR1 and CRFR2 gave rise to similar concentration-response curves for cAMP accumulation, but CRFR2 underwent restricted collision coupling. Both CRFR1 and CRFR2 formed constitutive oligomers at the cell surface and recruited β-arrestin upon agonist activation (as assessed by fluorescence resonance energy transfer microscopy in living cells). However, CRFR2, but not CRFR1, failed to undergo agonist-induced internalization. Likewise, agonist binding accelerated the diffusion rate of CRFR2 only (detected by fluorescence recovery after photobleaching and fluorescence correlation spectroscopy) but reduced the mobile fraction, which is indicative of local confinement. Fluorescence intensity distribution analysis demonstrated that the size of CRFR complexes was not changed. Disruption of the actin cytoskeleton abolished the agonist-dependent increase in CRFR2 mobility, shifted the agonist concentration curve for CRFR2 to the left, and promoted agonist-induced internalization of CRFR2. Our observations are incompatible with an agonist-induced change in monomer-oligomer equilibrium, but they suggest an agonist-induced redistribution of CRFR2 into a membrane microdomain that affords rapid diffusion but restricted mobility and that is stabilized by the actin cytoskeleton. Our data show that membrane anisotropy can determine the shape and duration of receptor-generated signals in a subtype-specific manner.
Footnotes
↵1 Current affiliation: The Ernest Gallo Clinic and Research Center, Emeryville, California.
This work was supported by the Austrian Science Fund/FWF [Grants P17076, P18706, N209]; the Wiener-, Wissenschafts-, Forschungs- und Technologiefonds (MA 05); and the Gallo Research Institute and Clinics.
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
doi:10.1124/mol.109.059139
-
ABBREVIATIONS:
- GPCR
- G protein-coupled receptor
- CFP
- cyan fluorescent protein
- YFP
- yellow fluorescent protein
- CRF
- corticotropin-releasing factor
- GFP
- green fluorescent protein
- CRFR
- corticotropin-releasing factor receptor
- C-SERT-Y
- cyan fluorescent protein-serotonin transporter-yellow fluorescent protein
- ECFP
- enhanced cyan fluorescent protein
- EYFP
- enhanced yellow fluorescent protein
- Y-DAT
- yellow fluorescent protein-dopamine transporter
- FCS
- fluorescence correlation spectroscopy
- FIDA
- fluorescence intensity distribution analysis
- FRAP
- fluorescence recovery after photobleaching
- TM
- transmembrane
- HEK
- human embryonic kidney
- GTPγS
- guanosine 5′-O-(3-thio)triphosphate
- MβCD
- methyl-β-cyclodextrin.
- Received July 3, 2009.
- Accepted September 11, 2009.
- © 2009 The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|